153 related articles for article (PubMed ID: 874470)
1. The demonstration of a change in responsiveness of mice to physostigmine and atropine after withdrawal from long-term haloperidol pretreatment.
Dunstan R; Jackson DM
J Neural Transm; 1977; 40(3):181-9. PubMed ID: 874470
[TBL] [Abstract][Full Text] [Related]
2. The demonstration of a change in adrenergic receptor sensitivity in the central nervous system of mice after withdrawal from long-term treatment with haloperidol.
Dunstan R; Jackson DM
Psychopharmacology (Berl); 1976 Jul; 48(1):105-14. PubMed ID: 9656
[TBL] [Abstract][Full Text] [Related]
3. The effect of dopamine receptor agonist treatment on haloperidol-induced supersensitivity in mice.
Fayle P; Jackson DM; Jenkins OF; Lafferty PA
Pharmacol Biochem Behav; 1985 Nov; 23(5):715-20. PubMed ID: 4080755
[TBL] [Abstract][Full Text] [Related]
4. Interactions of drugs acting on central dopamine receptors and cholinoceptors on yawning responses in the rat induced by apomorphine, bromocriptine or physostigmine.
Zarrindast MR; Poursoltan M
Br J Pharmacol; 1989 Apr; 96(4):843-8. PubMed ID: 2663110
[TBL] [Abstract][Full Text] [Related]
5. The effect of apomorphine and clonidine on locomotor activity in mice after long term treatment with haloperidol.
Dunstan R; Jackson DM
Clin Exp Pharmacol Physiol; 1977; 4(2):131-41. PubMed ID: 195762
[TBL] [Abstract][Full Text] [Related]
6. Modification of apomorphine-, physostigmine- and pilocarpine-induced yawning after long-term treatment with neuroleptic or cholinergic agents.
Ushijima I; Noda Y; Mizuki Y; Yamada M
Arch Int Pharmacodyn Ther; 1984 Oct; 271(2):180-8. PubMed ID: 6150689
[TBL] [Abstract][Full Text] [Related]
7. Lithium in combination with haloperidol or thyrotropin-releasing hormone induces jumping in mice.
Ushijima I; Yamada K; Furukawa T
Psychopharmacology (Berl); 1982; 76(2):136-8. PubMed ID: 6805023
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
Lassen JB
Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
[TBL] [Abstract][Full Text] [Related]
9. Jumping behavior induced by thyrotropin releasing hormone in combination with apomorphine in mice.
Ushijima I; Yamada K; Noda Y; Furukawa T
Psychopharmacology (Berl); 1982; 76(1):1-4. PubMed ID: 6281836
[TBL] [Abstract][Full Text] [Related]
10. Presynaptic dopamine receptors in the pithed rat: characterization with apomorphine and comparison with central dopamine autoreceptors.
Hietala J; MacDonald E; Scheinin M
Acta Pharmacol Toxicol (Copenh); 1986 Oct; 59(4):291-7. PubMed ID: 3799208
[TBL] [Abstract][Full Text] [Related]
11. The role of cholinergic supersensitivity in the medical symptoms associated with withdrawal of antipsychotic drugs.
Luchins DJ; Freed WJ; Wyatt RJ
Am J Psychiatry; 1980 Nov; 137(11):1395-8. PubMed ID: 6108078
[TBL] [Abstract][Full Text] [Related]
12. Alteration in dopaminergic and muscarinic cholinergic receptors after subchronic treatment with haloperidol in the developing rat brain.
Kajiyama H; Nomura Y
J Pharmacobiodyn; 1981 Feb; 4(2):85-90. PubMed ID: 7196947
[TBL] [Abstract][Full Text] [Related]
13. Dopaminergic and cholinergic interaction in cataleptic responses in mice.
Ushijima I; Kawano M; Kaneyuki H; Suetsugi M; Usami K; Hirano H; Mizuki Y; Yamada M
Pharmacol Biochem Behav; 1997 Sep; 58(1):103-8. PubMed ID: 9264077
[TBL] [Abstract][Full Text] [Related]
14. Effects of apomorphine administration on locomotor activity of control and experimental rats withdrawn from long-term haloperidol treatment.
Bernardi MM; Palermo-Neto J
Gen Pharmacol; 1983; 14(5):545-7. PubMed ID: 6685669
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the effects of cholinergic and dopaminergic agents on scopolamine-induced hyperactivity in mice.
Shannon HE; Peters SC
J Pharmacol Exp Ther; 1990 Nov; 255(2):549-53. PubMed ID: 2243341
[TBL] [Abstract][Full Text] [Related]
16. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
Breese GR; Napier TC; Mueller RA
J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
[TBL] [Abstract][Full Text] [Related]
17. Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.
Bourson A; Moser PC
Psychopharmacology (Berl); 1990; 100(2):168-72. PubMed ID: 1689500
[TBL] [Abstract][Full Text] [Related]
18. Anticholinergic properties of antipsychotic drugs and their relation to extrapyramidal side-effects.
Sayers AC; Bürki HR; Ruch W; Asper H
Psychopharmacology (Berl); 1976 Dec; 51(1):15-22. PubMed ID: 13446
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic and cholinergic influences on motor behavior in chickens.
Sanberg PR
J Comp Psychol; 1983 Mar; 97(1):59-68. PubMed ID: 6872506
[TBL] [Abstract][Full Text] [Related]
20. [The antiataxic mechanism of TRH in rolling mouse Nagoya: the effects of pretreatment with dopaminergic and cholinergic drugs].
Matsui K; Ando K
Jikken Dobutsu; 1984 Oct; 33(4):465-9. PubMed ID: 6440800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
